FDA Inspection 1231715 — Oxavita SRL
The FDA completed an inspection of Oxavita SRL on Feb 2, 2024 in Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 2, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Buenos Aires (Argentina)